Pennsylvania legislation · 2025-2026 Regular Session
Pennsylvania HR529: A Resolution designating the week of September 20 through 27, 2026, as "Idiopathic Pulmonary Fibrosis Research and Awareness Week" in Pennsylvania to increase awareness and understanding of idiopathic pulmonary fibrosis to support improved diagnosis and treatment.
Status: In committee, June 29, 2026
What the bill says
A resolution Designating the week of September 20 through 27, 2026, as "Idiopathic Pulmonary Fibrosis Research and Awareness Week" in Pennsylvania to increase awareness and understanding of idiopathic pulmonary fibrosis to support improved diagnosis and treatment.
From the introduced text, May 20, 2026:
A RESOLUTION Designating the week of September 20 through 27, 2026, as "Idiopathic Pulmonary Fibrosis Research and Awareness Week" in Pennsylvania to increase awareness and understanding of idiopathic pulmonary fibrosis to support improved diagnosis and treatment. WHEREAS, Idiopathic pulmonary fibrosis is a debilitating and generally fatal disease marked by progressive scarring of the lungs, causing an irreversible loss of the lung tissue's ability to transport oxygen; and WHEREAS, Idiopathic pulmonary fibrosis progresses quickly, often causing disability or death within three to five years; and WHEREAS, Idiopathic pulmonary fibrosis is the most common form of interstitial lung disease; and WHEREAS, There is no proven cause of idiopathic pulmonary fibrosis, and it is often misdiagnosed or underdiagnosed; and WHEREAS, Idiopathic pulmonary fibrosis is five times more common than cystic fibrosis and Lou Gehrig's disease, yet the disease remains virtually unknown and receives a fraction of the research funding; and WHEREAS, It is estimated that idiopathic pulmonary fibrosis affects between 132,000 to 200,000 individuals in the United States and more than 48,000 new cases are diagnosed each year; and WHEREAS, Approximately 40,000 people die each year due to idiopathic pulmonary fibrosis, which is similar to the number of deaths that occur due to breast cancer; and WHEREAS, Approximately 7,000 Pennsylvanians suffer from idiopathic pulmonary fibrosis; and WHEREAS, This Commonwealth has become a leader …
Sponsors
- Kathy RAPP (R, 065) · primary sponsor
- Arvind Venkat (D, 30)
- Robert KAUFFMAN (R, 089)
- Tina Pickett (R, 110)
- Nikki Rivera (D, 96)
- Patrick Gallagher (D, 173)
- David Rowe (R, 85)
- David Zimmerman (R, 99)
Latest actions
- : Laid on the table (Pursuant to House Rule 71), June 29, 2026
- : Reported as committed, June 2, 2026
- : Referred to HEALTH, May 20, 2026
Votes
- House Health: Re-report Bill As Committed (June 2, 2026): 26 yea, 0 nay, passed
Subjects: HEALTH
Common questions
- What is HR529?
- HR529 is a bill in the Pennsylvania Legislature (2025-2026 Regular Session): A Resolution designating the week of September 20 through 27, 2026, as "Idiopathic Pulmonary Fibrosis Research and Awareness Week" in Pennsylvania to increase awareness and understanding of idiopathic pulmonary fibrosis to support improved diagnosis and treatment.
- What does HR529 do?
- In its own words: A resolution Designating the week of September 20 through 27, 2026, as "Idiopathic Pulmonary Fibrosis Research and Awareness Week" in Pennsylvania to increase awareness and understanding of idiopathic pulmonary fibrosis to support improved diagnosis and treatment.
- What is the status of HR529?
- In committee as of June 29, 2026. Latest action: Laid on the table (Pursuant to House Rule 71), June 29, 2026 (June 29, 2026).
- Who sponsored HR529?
- Kathy RAPP (R, 065), with 7 co-sponsors.
- Where is the official record for HR529?
- On the Pennsylvania Legislature website: https://www.palegis.us/legislation/bills/2025/hr529
Source: official Pennsylvania record. Tracked by Delilah, AI for legislation across all 50 states and Congress.